Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
An adverse outcome pathway (AOP) describes the causal linkage between initial molecular events and an adverse outcome at individual or population levels. Whilst there has been considerable momentum in AOP development, far less attention has been paid to how AOPs might be practically applied for different regulatory purposes. This paper proposes a scientific confidence framework (SCF) for evaluating and applying a given AOP for different regulatory purposes ranging from prioritizing chemicals for further evaluation, to hazard prediction, and ultimately, risk assessment. The framework is illustrated using three different AOPs for several typical regulatory applications. The AOPs chosen are ones that have been recently developed and/or published, namely those for estrogenic effects, skin sensitisation, and rodent liver tumor promotion. The examples confirm how critical the data-richness of an AOP is for driving its practical application. In terms of performing risk assessment, human dosimetry methods are necessary to inform meaningful comparisons with human exposures; dosimetry is applied to effect levels based on non-testing approaches and in vitro data. Such a comparison is presented in the form of an exposure:activity ratio (EAR) to interpret biological activity in the context of exposure and to provide a basis for product stewardship and regulatory decision making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Wetmore, B. A., Wambaugh, J. F., Ferguson, S. S., Sochaski, M. A., Rotroff, D. M., Freeman, K., Clewell, H. J., Dix, D. J., Andersen, M. E., Houck, K. A., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr254 · Cited by 415
Morgan, R. E., van Staden, C. J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R. T., Afshari, C. A., & Hamadeh, H. K. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft176 · Cited by 243 · cited 1×
“In fact, as will be seen, the incorporation of exposure is often critical for increasing the predictive power of models (Morgan et al., 2013).”
BackgroundTwenty-Four Hour Human Urine and Serum Profiles of Bisphenol A during High-Dietary Exposure
Teeguarden, J. G., Calafat, A. M., Ye, X., Doerge, D. R., Churchwell, M. I., Gunawan, R., & Graham, M. K. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr160 · Cited by 215 · cited 1×
“However, the dosimetry for some chemicals that act via a selective mechanism in vitro remains necessary for understanding in vivo results and for AOP development (Hengstler et al., 2011; Teeguarden et al., 2011, 2013; Teeguarden and Hanson-Drury, 2013).”
BackgroundKennedy, G. D., Nukaya, M., Moran, S. M., Glover, E., Weinberg, S., Balbo, S., Hecht, S. S., Pitot, H. C., Drinkwater, N. R., & Bradfield, C. A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu065 · Cited by 42 · cited 4×
“Recently, evidence involving inflammation obtained with (Tumor necrosis factor alpha) TNFa knockout mouse model has shown the importance of inflammatory cytokines in driving the mouse liver tumor response to TCDD (Pande et al., 2005; Kennedy et al., 2014).”
BackgroundInfluentialUse and validation of HT/HC assays to support 21st century toxicity evaluations
Patlewicz, G., Simon, T., Goyak, K., Phillips, R. D., Rowlands, J. C., Seidel, S. D., & Becker, R. A. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.12.008 · Cited by 40
Self-citation
Cited by
Toxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Tollefsen, K. E., Scholz, S., Cronin, M. T., Edwards, S. W., de Knecht, J., Crofton, K., Garcia-Reyero, N., Hartung, T., Worth, A., & Patlewicz, G. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.09.009 · Cited by 377
Self-citationThomas, R. S., Bahadori, T., Buckley, T. J., Cowden, J., Deisenroth, C., Dionisio, K. L., Frithsen, J. B., Grulke, C. M., Gwinn, M. R., Harrill, J. A., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz058 · Cited by 373
Self-citationScreening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
Browne, P., Judson, R. S., Casey, W. M., Kleinstreuer, N. C., & Thomas, R. S. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02641 · Cited by 276
Halappanavar, S., van den Brule, S., Nymark, P., Gaté, L., Seidel, C., Valentino, S., Zhernovkov, V., Høgh Danielsen, P., De Vizcaya, A., Wolff, H., et al. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00344-4 · Cited by 246
Metadata
- Authors
- Patlewicz, G., Simon, T. W., Rowlands, J. C., Budinsky, R. A., & Becker, R. A.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 71
- Issue
- 3
- Pages
- 463-477
- ISSN
- 0273-2300 (ISSN-L)
- OpenAlex
- W2053772923
- Cited by
- 108
- References
- 7
- FWCI
- 28.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. https://app.cochat.ai/papers/10.1016/j.yrtph.2015.02.011
- The paper
- Patlewicz, G., Simon, T. W., Rowlands, J. C., Budinsky, R. A., & Becker, R. A. (2015). Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2015.02.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.